Skip to main content
NVDA+1.04%AAPL-0.27%MSFT-0.11%GOOGL+0.93%AMZN+0.71%TSM+1.76%SPCX+1.35%META-0.90%AVGO+4.46%TSLA+2.64%LLY+0.79%BRK-B-0.65%MU+2.20%SKHY+2.40%WMT-0.74%JPM+0.23%AMD+4.25%XOM-0.49%V-0.69%JNJ+0.02%ASMLa+0.99%MA-0.55%ABBV-0.39%INTC+3.88%CVX-0.48%1398.HK+2.15%0700.HK-0.31%COST-0.71%CSCO+0.51%KO-0.12%ORCL+3.67%PG-0.80%UNH+0.04%1816.HK+1.32%BAC+0.33%3988.HK+0.66%HD-0.65%CAT+1.85%0857.HK-0.98%PM-0.25%0939.HK+0.81%AP2d+0.27%AMAT+0.43%1288.HK+0.60%GE+0.49%LRCX+0.42%DELL+3.23%0005.HK-5.56%HSBA.L-6.60%NVS+1.43%NZDMXN+0.74%USDJPY+0.64%NZDJPY+0.61%AUDJPY+0.61%EURUSD-0.52%CADJPY+0.51%EURNZD-0.51%AUDDKK+0.50%EURAUD-0.48%USDCHF+0.46%EURSEK-0.45%AUDCHF+0.44%NZDCHF+0.44%USDMXN+0.44%GBPUSD-0.42%GBPTRY+0.41%GBPNZD-0.39%GBPAUD-0.39%EURCAD-0.37%NZDSGD+0.32%CADCHF+0.32%GBPHKD+0.32%EURCNH-0.31%CHFSEK-0.31%GBPCAD-0.30%EURNOK-0.30%EURHKD-0.29%GBPMXN-0.28%USDDKK+0.27%EURZAR-0.26%NOKJPY+0.26%EURSGD-0.25%AUDSGD+0.24%USDPLN+0.22%SGDJPY+0.21%GBPJPY+0.21%AUDNOK+0.20%CHFJPY+0.19%GBPZAR-0.18%USDSEK-0.18%USDTRY+0.18%GBPSGD-0.17%USDILS+0.16%CHFNOK-0.16%USDCAD+0.15%EURJPY+0.13%CHFSGD-0.11%NZDCAD+0.11%AUDCAD+0.10%EURGBP-0.09%EURCHF-0.07%EURPLN-0.05%USDCOP-0.04%AUDUSD-0.03%USDHKD+0.03%USDCNH-0.03%NZDUSD-0.03%USDNOK-0.03%GBPCHF+0.02%EURCZK-0.02%USDSGD+0.02%PLNJPY+0.02%USDZAR+0.02%AUDNZD-0.02%USDTHB-0.01%EURDKK0.00%COCOA+2.03%COFFEE-1.40%W1-0.81%XNGUSD-0.80%HG1+0.77%C1-0.44%XPTUSD-0.38%S1-0.32%COTTON-0.31%UKOIL-0.31%GAUUSD+0.30%XAUUSD+0.30%BTCUSD+0.23%ETHUSD+23.96%USDTUSD+0.03%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.09%ZECUSDT+3.20%DOGEUSD+20.65%XMRUSDT-0.13%LINKUSD+25.58%BCHUSDT+1.76%XLMUSD-0.60%UNIUSD-0.32%LTCUSD+17.89%SUIUSD+0.20%HBARUSDT-1.48%TONUSD+41.71%TAOUSDT-0.59%AAVEUSD-2.76%DOTUSDT-1.98%ICPUSDT-1.79%ONDOUSDT-0.62%WLDUSDT-1.01%ARBUSDT-0.37%JUPUSDT-0.42%INJUSDT-0.86%ATOMUSDT-0.88%STXUSDT-1.40%TIAUSDT-3.81%PYTHUSDT-2.81%FETUSDT+1.81%SEIUSDT+0.54%IMXUSDT-0.66%GRTUSDT-0.90%OPUSDT-1.09%WIFUSDT-1.72%IOTAUSDT+0.24%POLUSDT-1.39%AXSUSDT-0.22%EOSUSDT+1.53%FARTCOINUSDT+1.27%DYDXUSDT-0.20%GALAUSDT-1.33%ORDIUSDT+0.52%RONINUSDT+0.02%NOTUSDT+1.92%NVDA+1.04%AAPL-0.27%MSFT-0.11%GOOGL+0.93%AMZN+0.71%TSM+1.76%SPCX+1.35%META-0.90%AVGO+4.46%TSLA+2.64%LLY+0.79%BRK-B-0.65%MU+2.20%SKHY+2.40%WMT-0.74%JPM+0.23%AMD+4.25%XOM-0.49%V-0.69%JNJ+0.02%ASMLa+0.99%MA-0.55%ABBV-0.39%INTC+3.88%CVX-0.48%1398.HK+2.15%0700.HK-0.31%COST-0.71%CSCO+0.51%KO-0.12%ORCL+3.67%PG-0.80%UNH+0.04%1816.HK+1.32%BAC+0.33%3988.HK+0.66%HD-0.65%CAT+1.85%0857.HK-0.98%PM-0.25%0939.HK+0.81%AP2d+0.27%AMAT+0.43%1288.HK+0.60%GE+0.49%LRCX+0.42%DELL+3.23%0005.HK-5.56%HSBA.L-6.60%NVS+1.43%NZDMXN+0.74%USDJPY+0.64%NZDJPY+0.61%AUDJPY+0.61%EURUSD-0.52%CADJPY+0.51%EURNZD-0.51%AUDDKK+0.50%EURAUD-0.48%USDCHF+0.46%EURSEK-0.45%AUDCHF+0.44%NZDCHF+0.44%USDMXN+0.44%GBPUSD-0.42%GBPTRY+0.41%GBPNZD-0.39%GBPAUD-0.39%EURCAD-0.37%NZDSGD+0.32%CADCHF+0.32%GBPHKD+0.32%EURCNH-0.31%CHFSEK-0.31%GBPCAD-0.30%EURNOK-0.30%EURHKD-0.29%GBPMXN-0.28%USDDKK+0.27%EURZAR-0.26%NOKJPY+0.26%EURSGD-0.25%AUDSGD+0.24%USDPLN+0.22%SGDJPY+0.21%GBPJPY+0.21%AUDNOK+0.20%CHFJPY+0.19%GBPZAR-0.18%USDSEK-0.18%USDTRY+0.18%GBPSGD-0.17%USDILS+0.16%CHFNOK-0.16%USDCAD+0.15%EURJPY+0.13%CHFSGD-0.11%NZDCAD+0.11%AUDCAD+0.10%EURGBP-0.09%EURCHF-0.07%EURPLN-0.05%USDCOP-0.04%AUDUSD-0.03%USDHKD+0.03%USDCNH-0.03%NZDUSD-0.03%USDNOK-0.03%GBPCHF+0.02%EURCZK-0.02%USDSGD+0.02%PLNJPY+0.02%USDZAR+0.02%AUDNZD-0.02%USDTHB-0.01%EURDKK0.00%COCOA+2.03%COFFEE-1.40%W1-0.81%XNGUSD-0.80%HG1+0.77%C1-0.44%XPTUSD-0.38%S1-0.32%COTTON-0.31%UKOIL-0.31%GAUUSD+0.30%XAUUSD+0.30%BTCUSD+0.23%ETHUSD+23.96%USDTUSD+0.03%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.09%ZECUSDT+3.20%DOGEUSD+20.65%XMRUSDT-0.13%LINKUSD+25.58%BCHUSDT+1.76%XLMUSD-0.60%UNIUSD-0.32%LTCUSD+17.89%SUIUSD+0.20%HBARUSDT-1.48%TONUSD+41.71%TAOUSDT-0.59%AAVEUSD-2.76%DOTUSDT-1.98%ICPUSDT-1.79%ONDOUSDT-0.62%WLDUSDT-1.01%ARBUSDT-0.37%JUPUSDT-0.42%INJUSDT-0.86%ATOMUSDT-0.88%STXUSDT-1.40%TIAUSDT-3.81%PYTHUSDT-2.81%FETUSDT+1.81%SEIUSDT+0.54%IMXUSDT-0.66%GRTUSDT-0.90%OPUSDT-1.09%WIFUSDT-1.72%IOTAUSDT+0.24%POLUSDT-1.39%AXSUSDT-0.22%EOSUSDT+1.53%FARTCOINUSDT+1.27%DYDXUSDT-0.20%GALAUSDT-1.33%ORDIUSDT+0.52%RONINUSDT+0.02%NOTUSDT+1.92%
FG

Fulgent Genetics, Inc. (FLGT)

NASDAQ • Healthcare

$20.22
+$0.11 (+0.6%)
Market open

Last close at October 26, 2026 at 20:00 UTC

Open$20.14
Previous Close$20.22
Day Range$20.14 - $20.53
Avg. Volume (3M)271K
Market Cap$556.3M
52 Week Range
$13.46$31.04
Next EarningsIn 9 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$85.3M100%
Gross Profitminus cost of goods$25.6M30%

In plain terms: out of every $100 in revenue, Fulgent Genetics, Inc. currently loses $35.

Fundamentals & Financials

Revenue (TTM)
$323.9M
Net Income (TTM)
-$84.3M
EPS (TTM)
-$2.82
ROA (TTM)
-7.75%
Current Ratio
6.34
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+433.3%Q1 2026$0.16
-3.4%Q2 2026-$0.36
-26.1%Q3 2026-$0.58
Next

Nov 5

in 9 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -26.1%

Fulgent Genetics’ revenue in the second fiscal quarter of 2026 trailed consensus, with results reported July 30, 2026 showing revenue rose 4.4% to about $85.4 million, but still came in at $85.4 million versus a $94.0 million estimate (-9.2%, trailed). The top line reflected continued demand across its laboratory testing and genomic analysis offering, including molecular diagnostic and broader genetic testing services. Profitability remained pressured, with gross profit of roughly $25.7 million translating to a gross margin of about 30%, while operating loss was around $33.9 million and operating margin was near -40%. Net income was a loss of roughly $29.5 million, down 55.8% from a loss of about $19.0 million a year ago. Cash flow also ran negative, with negative operating cash flow of about $23.8 million, alongside $23.8 million of share repurchases during the quarter. For the next period, consensus calls for EPS of -$0.65 on revenue of $86.3 million.

Next report — what to expect

Fulgent Genetics, Inc. (FLGT) reports earnings on November 6, 2026. Wall Street expects EPS of -$0.65 on revenue of $86.3 million; for trailing context, revenue rose +4.4% year over year last quarter. FLGT has beaten EPS in 6 of its 8 most recent quarters, making any update to demand and margins a key watch.

View full earnings history

About Fulgent Genetics, Inc.

Fulgent Genetics, Inc. provides laboratory testing and genomic analysis in healthcare and trades on the NASDAQ under FLGT. The company delivers COVID-19 testing services, molecular diagnostic testing services, and broader genetic testing, with $322.7 million of revenue in FY2025. It serves customers globally across clinical, institutional, governmental, corporate, and direct-to-patient channels.

Name
Fulgent Genetics, Inc.
CEO
Ming Hsieh
Website
www.fulgentgenetics.com
Industry
Healthcare
Year Founded
2011
Employees
1,315

Today's Snapshot

AI-generated

FLGT ended yesterday 0.6% up at 20.22.

Trading Volume

Below 10d avg (241.4K)

191.1K

vs S&P 500 Today

Inline with Market

-0.10%

Updated: October 27, 2026 at 12:15 UTC

Technical Indicators

1 Buy2 Neutral5 Sell
FLGT displays a short-term bearish tilt as the market sits below several short- and medium-term averages and momentum indicators show downside pressure, including a negative MACD and falling momentum. Volume trends are unfavorable with OBV declining, while ADX signals a lack of strong directional conviction and ATR indicates moderate volatility. Some longer-term averages are not fully broken, producing a mixed backdrop, and the pivot is close to the current price. Technical takeaway: Overall sell bias driven by short-term moving averages and weakening momentum, despite limited trend strength.
All signals
  • EMA (5 indicators)$20.21 - $20.95
    Sell
  • RSI (14)45.03
    Neutral
  • Stochastic %K (14, 3, 3)26.54
    Neutral
  • MACD Level (12, 26)-0.22
    Sell

Peers & Related Assets

NTRANatera, Inc.
$404.9+0.2%
GHGuardant Health, Inc.
$173.25+2.5%
NEONeoGenomics, Inc.
$16.69+0.6%
WGSGeneDx Holdings Corp.
$61.26+9.1%
MYGNMyriad Genetics, Inc.
$6.02+3.4%
BLLNBillionToOne, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.